Cargando…
β-amyloid in biological samples: not all Aβ detection methods are created equal
Autores principales: | Adlard, Paul A., Li, Qiao-Xin, McLean, Catriona, Masters, Colin L., Bush, Ashley I., Fodero-Tavoletti, Michelle, Villemagne, Victor, Barnham, Kevin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131196/ https://www.ncbi.nlm.nih.gov/pubmed/25165449 http://dx.doi.org/10.3389/fnagi.2014.00203 |
Ejemplares similares
-
Quantification of N-terminal amyloid-β isoforms reveals isomers are the most abundant form of the amyloid-β peptide in sporadic Alzheimer’s disease
por: Mukherjee, Soumya, et al.
Publicado: (2021) -
Assessing THK523 selectivity for tau deposits in Alzheimer’s disease and non–Alzheimer’s disease tauopathies
por: Fodero-Tavoletti, Michelle T, et al.
Publicado: (2014) -
Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
por: Fandos, Noelia, et al.
Publicado: (2017) -
Not all vinculins are created equal
por: Leslie, Mitch
Publicado: (2014) -
Pharmacotherapeutic targets in Alzheimer's disease
por: Biran, Yif'at, et al.
Publicado: (2009)